ArticleActa clinica Croatica2022

EFFECTS OF HYDROXYCHLOROQUINE PLUS FAVIPIRAVIR TREATMENT ON THE CLINICAL COURSE AND BIOMARKERS IN HOSPITALIZED COVID-19 PATIENTS WITH PNEUMONIA.

Leman Acun Delen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.